Inventor · disambiguated record
Markus Bergauer
Also filed as: BERGAUER MARKUS
8 granted patents·3 pending applications·64 citations·filing 2005–2011
86Inventor score
Technology areasA61P
Top patents by PatentIndex Score
11 records- 0190US7655693B2CompoundsGLAXO GROUP LTD·Filed 2006·Granted Feb 2, 2010·14 cites·14 claims
- 0288US7855218B2CompoundsCONVERGENCE PHARMACEUTICALS·Filed 2006·Granted Dec 21, 2010·13 cites·16 claims
- 0387US8153681B2Method of treating epilepsy by administering 5-(4{[(2-fluorophenyl)methyl]oxy}phenyl)prolinamideALVARO GIUSEPPE·Filed 2009·Granted Apr 10, 2012·9 cites·8 claims
- 0486US7803833B2CompoundsGLAXO GROUP LTD·Filed 2006·Granted Sep 28, 2010·10 cites·22 claims
- 0584US8153623B2CompoundsALVARO GIUSEPPE·Filed 2010·Granted Apr 10, 2012·9 cites·18 claims
- 0684US8143306B2Methods of treating bipolar disordersALVARO GIUSEPPE·Filed 2011·Granted Mar 27, 2012·8 cites·12 claims
- 0772US7592346B2Quinoline and quinazoline derivatives having affinity for 5HT1-type receptorsGLAXO GROUP LTD·Filed 2008·Granted Sep 22, 2009·1 cites·25 claims
- 0866US7732600B2Quinoline and quinazoline derivatives having affinity for 5HT1-type receptorsGLAXO GROUP LTD·Filed 2009·Granted Jun 8, 2010·0 cites·4 claims
- 0951US2010204273A1Quinoline and Quinazoline Derivatives Having Affinity for 5HT1-Type ReceptorsGLAXO GROUP LTD·Filed 2010·Application pending·0 cites
- 1049US2010130583A1Prolinamide derivatives as modulators of voltage-gated sodium channelsGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 1136US2012022056A1Fused tricyclic derivatives for the treatment of psychotic disordersBENTLEY JONATHAN·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Markus Bergauer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →